Key facts
- This page summarizes David Moatazedi's Form 4 filing for BIOMERICA INC (BMRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Aug 2026, 17:26.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
On August 26, 2026, the reporting person acquired 10,000 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.